triphenylmethane has been researched along with Leishmaniasis, Cutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, J; de Souza Pietra, RC; Fernandes, AP; Ferreira, LA; Fried, L; Lefkove, B; Rabello, A; Rodrigues, LF; Teixeira, E | 1 |
1 other study(ies) available for triphenylmethane and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis.
Topics: Animals; Cell Death; Dose-Response Relationship, Drug; Female; Humans; Intracellular Space; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Life Cycle Stages; Mice; Molecular Weight; Trityl Compounds | 2013 |